SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Abgenix, Inc. (ABGX) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (395)11/30/2004 2:40:29 PM
From: Icebrg  Respond to of 590
 
CP-675,206

There are three currently ongoing clinical trials listed at

clinicaltrials.gov

One of them being in combination with a vaccine. Abgenix cannot have been too happy to see Cell Genesys go ahead testing GVAX in a combination with MDX-010.

Erik



To: nigel bates who wrote (395)11/30/2004 6:17:41 PM
From: Icebrg  Respond to of 590
 
>>Six patients achieved complete remission,>>

I wonder what trial those results came from? It would be interesting to know some of the details. All I have been able to find is a trial reported at ASCO 2004 with 2 and later maybe 3 CRs.

Erik


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News